PRZOOM - /newswire/ -
London, Greater London, United Kingdom, 2008/01/31 - eyeforpharma, announced today that the 5th annual Patient Compliance & Communication conference, London, 11-12 June 2008 has secured its full speaker faculty including leading executives from Pharma, Payers and Stakeholder groups.
The conference comprises a carefully selected faculty of speakers, ranging from Big Pharma like Pfizer to payers, patient advocacy groups, nurses, pharmacists and other important stakeholders. Keynotes include:
• Bernd Majentry, Global Head of Brand RoI, Bayer Healthcare;
• Keith Allan, Head of Advocacy, Novartis;
• Michael Morgan-Curran, Innovation Group, AstraZeneca;
• Marta Wielondek, Global Brand Director, Novartis;
• Chris Venn, European Brand Manager, Pfizer;
• Mark Heim, Group Marketing Leader, Nycomed;
• Manos Papadakis, Brand Manager, GSK;
• Wendy Clyne, Assistant Director: Medicines Partnership Programme, National Prescribing Centre;
• Clare Kerr, Pharmacy Services Manager, Lloyds Pharmacy;
• Janet Davies, Executive Director for Service Delivery, Royal College of Nurses;
• Steve Mott, CEO, Medicines.org.uk
Manos Papadakis, a Brand Manager of Cervarix at GlaxoSmithKline comments that "This is the perfect opportunity for brand managers from across Europe to gather and discuss the implications of the rapidly advancing patient compliance & communications area on our products. I envisage it could be one of the defining features of success in the near future."
The two day event taking place June 11-12 2008, London, comprises presentation sessions, roundtables, workshops, a networking evening and an exhibition hall. Some of the topics to be explored at the Summit are how patient compliance programmes can add value to a brand’s offerings in the marketplace, thus helping it gain reimbursement, fight generics and differentiate against other brands. Experts will also look at how to measure the financial RoI of compliance & communication programmes, how to understand and influence patient behaviour, how to work more effectively with key stakeholders, leveraging new media and multi-channel communications, and taking advantage of scalable technological solutions.
Keith Allan, of Novartis says that “I am involved with this conference because I believe we need to develop a meaningful partnership between the industry, stakeholders and patients to improve Patient Compliance. It offers an exceptional chance to ensure patients and receive optimal value from treatments, and that better quality of care is delivered"
eyeforpharma is offering Early Bird discounts to those who secure their place at the Summit early, with €300 knocked off the price of tickets to anyone registering before March 5th, making the cost €1495 for a full Silver Pass. In the interest of encouraging stakeholders such as patient advocacy groups to join in the debate, eyeforpharma are wiling to offer cost-price passes to this community to the event. To enquire about this, contact the event Director, Mark Walker (details below).
Further updates, full information on presentations and speakers, and details on other ticket options can all be found by downloading the brochure.